Thursday, September 27, 2018

Anti-PD-L1 Drug Boosts Survival in Stage III NSCLC https://t.co/PyZ93I9TEL


from Twitter https://twitter.com/fherehab2

September 26, 2018 at 11:34PM
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)